Published in

American Society for Microbiology, Journal of Clinical Microbiology, 9(59), 2021

DOI: 10.1128/jcm.00654-21

Links

Tools

Export citation

Search in Google Scholar

Evaluation of the Vitek 2, Phoenix, and MicroScan for Antimicrobial Susceptibility Testing of Stenotrophomonas maltophilia

Journal article published in 2021 by Ayesha Khan ORCID, Patricia J. Simner, Cesar A. Arias, April Abbott, Jennifer Dien Bard, Jennifer Dien Bard ORCID, Micah M. Bhatti, Romney M. Humphries ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Orange circle
Published version: archiving restricted
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Stenotrophomonas maltophilia causes high-mortality infections in immunocompromised hosts with limited therapeutic options. Many U.S. laboratories rely on commercial automated antimicrobial susceptibility tests (cASTs) and use CLSI breakpoints (BPs) for S. maltophilia .